Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  90 results for ""Double-Blind Method""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

TREOCAPA: prophylactic treatment of the ductus arteriosus in preterm infants by acetaminophen-statistical analysis plan for the randomized phase III group sequential trial.

Subjects: Acetaminophen*/Acetaminophen*/Acetaminophen*/adverse effects ; Acetaminophen*/Acetaminophen*/Acetaminophen*/therapeutic use ; Acetaminophen*/Acetaminophen*/Acetaminophen*/administration & dosage

  • Source: Trials [Trials] 2025 Feb 13; Vol. 26 (1), pp. 52. Date of Electronic Publication: 2025 Feb 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

Record details

×
Academic Journal

Ultra-low-dose estradiol and dydrogesterone for treatment of vasomotor symptoms in Europe and China.

  • Authors : Yu Q; Gynecological Endocrinology and Reproductive Center, Peking Union Medical College Hospital, Beijing, China.; Stevenson JC

Subjects: Dydrogesterone*/Dydrogesterone*/Dydrogesterone*/administration & dosage ; Estradiol*/Estradiol*/Estradiol*/administration & dosage ; Hot Flashes*/Hot Flashes*/Hot Flashes*/drug therapy

  • Source: Climacteric : the journal of the International Menopause Society [Climacteric] 2024 Oct; Vol. 27 (5), pp. 494-500. Date of Electronic Publication: 2024 Jul 30.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9810959 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Hypophosphatemia attenuates improvements in vitality after intravenous iron treatment in patients with inflammatory bowel disease.

Subjects: Quality of Life* ; Ferric Compounds*/Ferric Compounds*/Ferric Compounds*/administration & dosage ; Ferric Compounds*/Ferric Compounds*/Ferric Compounds*/therapeutic use

  • Source: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2024 Aug; Vol. 33 (8), pp. 2285-2294. Date of Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 9210257 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinical Evaluation of 16-Week Supplementation with 5HMO-Mix in Healthy-Term Human Infants to Determine Tolerability, Safety, and Effect on Growth.

Subjects: Bottle Feeding*/Bottle Feeding*/Bottle Feeding*/adverse effects ; Child Development* ; Food, Fortified*

  • Source: Nutrients [Nutrients] 2021 Aug 20; Vol. 13 (8). Date of Electronic Publication: 2021 Aug 20.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?

  • Authors : Kaufman-Janette J; Skin Associates of South Florida, Skin Research Institute, 4425, Ponce De Leon Boulevard, Suite 200, Coral Gables, FL 33146-1871, USA.; Cox SE

Subjects: Botulinum Toxins, Type A/Botulinum Toxins, Type A/Botulinum Toxins, Type A/*therapeutic use ; Skin Aging/Skin Aging/Skin Aging/*drug effects; Dose-Response Relationship, Drug

  • Source: Toxins [Toxins (Basel)] 2021 Jul 16; Vol. 13 (7). Date of Electronic Publication: 2021 Jul 16.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651

Record details

×
Academic Journal

Safety and Stability of Pulmonary Function in Patients with Decreased Respiratory Function Treated for Spasticity with OnabotulinumtoxinA.

  • Authors : Ayyoub Z; Rancho Los Amigos National Rehabilitation Center, Downey, CA 90242, USA.; Clinical Professor of Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA 90095, USA.

Subjects: Acetylcholine Release Inhibitors/Acetylcholine Release Inhibitors/Acetylcholine Release Inhibitors/*therapeutic use ; Botulinum Toxins, Type A/Botulinum Toxins, Type A/Botulinum Toxins, Type A/*therapeutic use ; Lower Extremity/Lower Extremity/Lower Extremity/*innervation

  • Source: Toxins [Toxins (Basel)] 2020 Oct 19; Vol. 12 (10). Date of Electronic Publication: 2020 Oct 19.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651

Record details

×
Academic Journal

Influence of pre-treatment blood pressure levels on antihypertensive drug benefits in diabetics: the roadmap experience.

  • Authors : Chatzikyrkou C; Clinic of Nephrology, Hypertension, Diabetes and Endocrinology, Health Campus Immunology, Infectiology and inflammation, Otto-von Guericke University, Magdeburg, Germany.; Nephrology Section, Hannover Medical School, Hannover, Germany.

Subjects: Diabetes Mellitus*/Diabetes Mellitus*/Diabetes Mellitus*/diagnosis; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use

  • Source: Blood pressure [Blood Press] 2020 Aug; Vol. 29 (4), pp. 247-255. Date of Electronic Publication: 2020 Apr 13.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9301454 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data.

Subjects: Microcirculation*; Diabetes Complications/Diabetes Complications/Diabetes Complications/*drug therapy ; Diabetes Complications/Diabetes Complications/Diabetes Complications/*prevention & control

  • Source: PloS one [PLoS One] 2020 Apr 13; Vol. 15 (4), pp. e0231196. Date of Electronic Publication: 2020 Apr 13 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.

  • Authors : Nagy S; Division of Developmental- and Neuropaediatrics, University Children's Hospital Basel (UKBB), University of Basel, Spitalstrasse 33, Postfach, 4031, Basel, Switzerland. .; Department of Neurology, University Hospital Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland. .

Subjects: Motor Activity/Motor Activity/Motor Activity/*drug effects ; Muscle, Skeletal/Muscle, Skeletal/Muscle, Skeletal/*drug effects ; Muscular Dystrophy, Duchenne/Muscular Dystrophy, Duchenne/Muscular Dystrophy, Duchenne/*drug therapy

  • Source: Trials [Trials] 2019 Nov 21; Vol. 20 (1), pp. 637. Date of Electronic Publication: 2019 Nov 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

Record details

×
  • 1-10 of  90 results for ""Double-Blind Method""